C-reactive Protein (CRP) in Patients With Myocarditis: A Systematic Review and Meta-Analysis

Bushra Ghulam1, Zahira Bashir2, Amber Khurshid Akram3

  • 1Biochemistry, Islamic International Medical College, Islamabad, PAK.

Cureus
|November 20, 2024
PubMed

Insights

C-reactive protein (CRP) levels are significantly higher in myocarditis patients compared to healthy individuals. This finding suggests CRP could be a valuable biomarker for diagnosing and predicting myocarditis outcomes.

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammatory Diseases

Background:

  • Myocarditis, an inflammation of the heart muscle, can be fatal and requires early diagnosis.
  • Current diagnostic methods for myocarditis are often complex or machine-dependent.
  • C-reactive protein (CRP) is a known indicator of inflammation in the body.

Purpose of the Study:

  • To investigate the correlation between C-reactive protein (CRP) levels and myocarditis.
  • To assess the potential of CRP as a diagnostic biomarker for myocarditis.

Main Methods:

  • A systematic literature search was conducted across PubMed, Google Scholar, and ScienceDirect.
  • Four eligible studies were selected for meta-analysis, comparing CRP levels in myocarditis patients versus healthy controls.
  • Study quality, bias, outliers, sensitivity, significance, and heterogeneity were evaluated.

Main Results:

  • A significant mean difference (MD) of 6.03 (95% CI: 2.41-9.64, p<0.00001) was observed, indicating elevated CRP in myocarditis patients.
  • High study quality and no significant bias or outliers were noted.
  • High heterogeneity (I²=99%) was present, but a fixed-effect model confirmed the significant elevation (MD: 5.08 (95% CI: 4.85-5.32)).

Conclusions:

  • Elevated C-reactive protein (CRP) levels are strongly associated with myocarditis.
  • CRP shows potential as a reliable biomarker for accurate diagnosis and prognosis of myocarditis.
  • Further research can validate CRP's role in clinical settings for myocarditis management.

Related Concept Videos

Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
59
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Pericarditis II: Clinical features and Diagnostic Tests01:19

Pericarditis II: Clinical features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
3